<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00294593</url>
  </required_header>
  <id_info>
    <org_study_id>IJL-FA-TH01</org_study_id>
    <nct_id>NCT00294593</nct_id>
  </id_info>
  <brief_title>Efficacy Study of Folinic Acid to Improve Mental Development of Children With Down Syndrome</brief_title>
  <official_title>One-year Double-blind Placebo-controlled Phase 2-3 Study to Evaluate the Effect of Oral Folinic Acid Treatment (1mg/kg/d) on the Psychomotor Development of Young Down Syndrome Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Jerome Lejeune</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondation Jérôme Lejeune</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut Jerome Lejeune</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether folinic acid can improve developmental
      quotient of young Down syndrome patients, given that these present signs of folate deficiency
      which are known to cause reversible neurological, psychiatric and cognitive disorders.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2000</start_date>
  <completion_date>December 2003</completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Score on a psychomotor development scale after a 6 and 12 months treatment</measure>
  </primary_outcome>
  <enrollment>120</enrollment>
  <condition>Down Syndrome</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>folinic acid</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Down syndrome without mosaicism

          -  age 3 to 30 months

          -  weight over 4 kg

          -  possible assessment by the revised Brunet-Lezine scale

        Exclusion Criteria:

          -  history of leukemia

          -  West syndrome or non-stable epilepsy

          -  non-stable thyroxin treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>30 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henri Blehaut, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Institut Jerome Lejeune</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Clotilde Mircher, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Jerome Lejeune</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut Jerome Lejeune</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Botez MI, Botez T, Leveille J, Bielmann P, Cadotte M. Neuropsychological correlates of folic acid deficiency: facts and hypotheses. In: Botez MI, Reynolds EH, eds. Folic acid in neurology, psychiatry and internal medicine. New York, Raven Press, 1979:435-461.</citation>
  </reference>
  <reference>
    <citation>Lejeune J. [Pathogenesis of mental impairment in trisomy 21]. Ann Genet. 1991;34(2):55-64. Review. French.</citation>
    <PMID>1836122</PMID>
  </reference>
  <verification_date>December 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 21, 2006</study_first_submitted>
  <study_first_submitted_qc>February 21, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 22, 2006</study_first_posted>
  <last_update_submitted>December 16, 2009</last_update_submitted>
  <last_update_submitted_qc>December 16, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 17, 2009</last_update_posted>
  <responsible_party>
    <name_title>Franck Sturtz</name_title>
    <organization>Institut Jerome Lejeune</organization>
  </responsible_party>
  <keyword>Down syndrome</keyword>
  <keyword>folinic acid therapy</keyword>
  <keyword>cognitive functions</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Down Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leucovorin</mesh_term>
    <mesh_term>Levoleucovorin</mesh_term>
    <mesh_term>Folic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

